

(Sharecast News) - Clinigen announced an increased and final all-cash offer from Triton of 925p per share on Monday.


(Sharecast News) - Pharmaceutical products and services company Clinigen reiterated its guidance for EBITDA growth in the 2022 financial year of betwe...


Clinigen holds earnings growth guidance after solid first half


CORRECT: UK shareholder meetings calendar - next 7 days


UK shareholder meetings calendar - next 7 days


Drugmaker Clinigen agrees to Triton's GBP1.2 billion takeover bid


AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project